Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer*, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart J. Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Bocchi, Michael Boehm, Dong-Ju Choi, Vijay Chopra, Eduardo ChuquiureNadia Giannetti, Stefan Janssens, Jian Zhang, Jose R. Gonzalez Juanatey, Sanjay Kaul, Hans-Peter Brunner-La Rocca, Bela Merkely, Stephen J. Nicholls, Sergio Perrone, Ileana Pina, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie-France Seronde, Jindrich Spinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faiez Zannad, EMPEROR-Reduced Trial Investigators

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science